ORIGINAL RESEARCH
Accepted on 28 Jul 2025
Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study
doi 10.3389/fimmu.2025.1562458
- 138 views